BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21204292)

  • 1. Practicing IEF-PAGE of EPO: the impact of detergents and sample application methods on analytical performance in doping control.
    Reichel C
    Drug Test Anal; 2010; 2(11-12):603-19. PubMed ID: 21204292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometric analysis of EPO IEF-PAGE interfering substances in nitrile examination gloves.
    Reichel C
    Drug Test Anal; 2012 Oct; 4(10):761-74. PubMed ID: 23081906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interference of heparin on IEF-PAGE of erythropoietins.
    Reichel C; Benetka E; Geisendorfer T; Scheiblhofer V; Abzieher F
    Drug Test Anal; 2010; 2(11-12):568-75. PubMed ID: 21204288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control.
    Reichel C; Kulovics R; Jordan V; Watzinger M; Geisendorfer T
    Drug Test Anal; 2009 Jan; 1(1):43-50. PubMed ID: 20355158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fc-fragment removal allows the EPO-Fc fusion protein to be detected in blood samples by IEF-PAGE.
    Postnikov P; Krotov G; Mesonzhnik N; Efimova Y; Rodchenkov G
    Drug Test Anal; 2015; 7(11-12):999-1008. PubMed ID: 26695487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Easy-to-use IEF compatible immunoaffinity purification of Erythropoietin from urine retentates.
    Reihlen P; Völker-Schänzer E; Majer B; Schänzer W
    Drug Test Anal; 2012 Nov; 4(11):813-7. PubMed ID: 22566398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doping control of biosimilar epoetin kappa and other recombinant erythropoietins after intravenous application.
    Okano M; Sato M; Kaneko E; Kageyama S
    Drug Test Anal; 2011; 3(11-12):798-805. PubMed ID: 22012825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of AMGEN clone 9G8A anti-Epo antibody for application in doping control.
    Reichel C; Benetka W; Lorenc B; Thevis M
    Drug Test Anal; 2016 Nov; 8(11-12):1131-1137. PubMed ID: 27552163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of intact recombinant human erythropoietins applied in doping by means of planar gel electrophoretic techniques and matrix-assisted laser desorption/ionisation linear time-of-flight mass spectrometry.
    Stübiger G; Marchetti M; Nagano M; Reichel C; Gmeiner G; Allmaier G
    Rapid Commun Mass Spectrom; 2005; 19(5):728-42. PubMed ID: 15700237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of high-throughput IEF-PAGE for EPO-doping testing.
    Reichel C
    Drug Test Anal; 2012 Sep; 4(9):728-32. PubMed ID: 22991138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined immuno-purification and detection of recombinant erythropoietins and activin receptor type II-Fc fusion proteins by isoelectric focusing for application in doping control.
    Martin L; Audran M; Marchand A
    Drug Test Anal; 2019 Jan; 11(1):168-172. PubMed ID: 30091846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defending Dynepo detection.
    Gmeiner G; Reichel C; Kulovics R; Scheiblhofer V
    Drug Test Anal; 2010; 2(11-12):526-32. PubMed ID: 21204285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parameters.
    Dehnes Y; Hemmersbach P
    Drug Test Anal; 2011 May; 3(5):291-9. PubMed ID: 21387570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An optimized SDS-PAGE protocol with a new blotting system for the initial testing procedure of ESAs in doping control.
    Martin L; Martin JA; Audran M; Marchand A
    Drug Test Anal; 2022 Jan; 14(1):181-187. PubMed ID: 33269539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomagnetic beads-based isolation of erythropoietins from urine and blood for sports anti-doping control.
    Desharnais P; Naud JF; Ayotte C
    Drug Test Anal; 2017 Nov; 9(11-12):1744-1752. PubMed ID: 28994210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in doping testing for erythropoietin.
    Reichel C
    Anal Bioanal Chem; 2011 Aug; 401(2):463-81. PubMed ID: 21637931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desialylation improves the detection of recombinant erythropoietins in urine samples analyzed by SDS-PAGE.
    Desharnais P; Naud JF; Ayotte C
    Drug Test Anal; 2013; 5(11-12):870-6. PubMed ID: 23720238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of high intensity exercise on isoelectric profiles and SDS-PAGE mobility of erythropoietin.
    Voss S; Lüdke A; Romberg S; Schänzer E; Flenker U; deMarees M; Achtzehn S; Mester J; Schänzer W
    Int J Sports Med; 2010 Jun; 31(6):367-71. PubMed ID: 20419620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR-PAGE after microdose injections.
    Dehnes Y; Shalina A; Myrvold L
    Drug Test Anal; 2013; 5(11-12):861-9. PubMed ID: 24190107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights for identification of doping with recombinant human erythropoietin micro-doses after high hydration.
    Martin L; Ashenden M; Bejder J; Hoffmann M; Nordsborg N; Karstoft K; Morkeberg J; Sharpe K; Lasne F; Marchand A
    Drug Test Anal; 2016 Nov; 8(11-12):1119-1130. PubMed ID: 27390252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.